Hi Sammy,
Totally disagree with any exclusivity. Anything that restricts the open use of the APP will be detrimental, particularly in 3rd world areas.
This question was put to TK at the CEO session, and he emphatically said there would be NO exclusive deals. Basically because there is no need. They need us, more than we need them. We can keep better control over pricing without exclusivity.
Companies are knocking the door down trying to get an advantage.
TK said that other Hospitals were also still offering to do trials.
Kind Regards
Phil.
RAP Price at posting:
29.5¢ Sentiment: Buy Disclosure: Held